<resource xmlns:datacite="http://datacite.org/schema/kernel-4">
<creators>
<creator>
<creatorName>Strohmayer, Carina (University of Veterinary Medicine Vienna)</creatorName>
<givenName>Carina</givenName>
<familyName>Strohmayer</familyName>
</creator>
<creator>
<creatorName>Brandt, Sabine (University of Veterinary Medicine Vienna)</creatorName>
<givenName>Sabine</givenName>
<familyName>Brandt</familyName>
</creator>
<creator>
<creatorName>Kneissl, Sibylle (University of Veterinary Medicine Vienna)</creatorName>
<givenName>Sibylle</givenName>
<familyName>Kneissl</familyName>
</creator>
<creator>
<creatorName>Redmer, Torben (University of Veterinary Medicine Vienna)</creatorName>
<givenName>Torben</givenName>
<familyName>Redmer</familyName>
</creator>
<creator>
<creatorName>Weissenbacher-Lang, Christiane (University of Veterinary Medicine)</creatorName>
<givenName>Christiane</givenName>
<familyName>Weissenbacher-Lang</familyName>
</creator>
<creator>
<creatorName>Jindra, Christoph (University of Veterinary Medicine Vienna)</creatorName>
<givenName>Christoph</givenName>
<familyName>Jindra</familyName>
</creator>
<creator>
<creatorName>Walter, Ingrid (University of Veterinary Medicine Vienna)</creatorName>
<givenName>Ingrid</givenName>
<familyName>Walter</familyName>
</creator>
<creator>
<creatorName>Klang, Andrea (University of Veterinary Medicine Vienna)</creatorName>
<givenName>Andrea</givenName>
<familyName>Klang</familyName>
</creator>
<creator>
<creatorName>Kummer, Stefan (University of Veterinary Medicine Vienna)</creatorName>
<givenName>Stefan</givenName>
<familyName>Kummer</familyName>
</creator>
</creators>
<titles>
<title>Tumor Cell Plasticity in Equine Papillomavirus-Positive Versus-Negative Squamous Cell Carcinoma of the Head and Neck</title>
</titles>
<publisher>MDPI</publisher>
<publicationYear>2022</publicationYear>
<descriptions>
<description descriptionType="Other">Squamous cell carcinoma of the head and neck (HNSCC) is a common malignant tumor in humans and animals. In humans, papillomavirus (PV)-induced HNSCCs have a better prognosis than papillomavirus-unrelated HNSCCs. The ability of tumor cells to switch from epithelial to mesenchymal, endothelial, or therapy-resistant stem-cell-like phenotypes promotes disease progression and metastasis. In equine HNSCC, PV-association and tumor cell phenotype switching are poorly understood. We screened 49 equine HNSCCs for equine PV (EcPV) type 2, 3 and 5 infection. Subsequently, PV-positive versus -negative lesions were analyzed for expression of selected epithelial (keratins, β-catenin), mesenchymal (vimentin), endothelial (COX-2), and stem-cell markers (CD271, CD44) by immunohistochemistry (IHC) and immunofluorescence (IF; keratins/vimentin, CD44/CD271 double-staining) to address tumor cell plasticity in relation to PV infection. Only EcPV2 PCR scored positive for 11/49 equine HNSCCs. IHC and IF from 11 EcPV2-positive and 11 EcPV2-negative tumors revealed epithelial-to-mesenchymal transition events, with vimentin-positive cells ranging between &lt;10 and &gt;50%. CD44- and CD271-staining disclosed the intralesional presence of infiltrative tumor cell fronts and double-positive tumor cell subsets independently of the PV infection status. Our findings are indicative of (partial) epithelial-mesenchymal transition events giving rise to hybrid epithelial/mesenchymal and stem-cell-like tumor cell phenotypes in equine HNSCCs and suggest CD44 and CD271 as potential malignancy markers that merit to be further explored in the horse.</description>
</descriptions>
<resourceType resourceTypeGeneral="Text">PDFDocument</resourceType>
<language>en</language>
<dates>
<date dateType="Created">2023-07-03T14:30:09.516Z</date>
</dates>
<subjects>
<subject>Cancer Stem-Cells; Epithelial-Mesenchymal Transition; Cadherin Down-Regulation; Beta-Catenin; Nuclear Translocation; Initiating Cells; Expression; Dna; Metastasis; Phenotype</subject>
</subjects>
<sizes>
<size>6741361 b</size>
</sizes>
<formats>
<format>application/pdf</format>
</formats>
<rightsList>
<rights rightsURI="http://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International</rights>
</rightsList>
</resource>
